Skip to Content

93 1041 (Diclofenac sodium extended-release 100 mg)

Pill imprint 93 1041 has been identified as Diclofenac sodium extended-release 100 mg.

Diclofenac is used in the treatment of back pain; frozen shoulder; ankylosing spondylitis; muscle pain; pain (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. There is positive evidence of human fetal risk during pregnancy. Diclofenac 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Diclofenac sodium extended-release 100 mg 93 1041
Diclofenac sodium extended-release 100 mg 93 1041 Front
Diclofenac sodium extended-release 100 mg 93 1041 Back
Diclofenac sodium extended-release 100 mg 93 1041
Diclofenac sodium extended-release
93 1041
100 mg
9.00 mm
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA
National Drug Code (NDC):
Inactive Ingredients:
polyethylene glycol
isopropyl alcohol
lactose anhydrous
magnesium stearate
povidone k90
silicon dioxide
magnesium silicate
D&C Red No. 27
lactose monohydrate
titanium dioxide
hydroxyethyl cellulose (4000 mpa.s at 1%)

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68682-0103 Oceanside Pharmaceuticals, Inc.
52959-0794 H.J. Harkins Company, Inc (repackager)
66336-0383 Dispensing Solutions Inc. (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.